# US 11,441,197 B2 · In silico design of mammalian promoters with user-defined functionality

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,441,197 B2
- Document ID: US11441197B2
- Status: Granted
- Kind: B2
- Application number: 16/605,308
- Filed: 2018-04-19
- Published: 2021-05-20
- Granted: 2022-09-13
- Earliest claimed: 2017-04-19
- Assignees: MedImmune, LLC
- Applicants: Medimmune Limited
- Inventors: Adam J. Brown; David C. James; Suzanne J. Gibson; Diane Hatton
- Web page: https://patentgrep.com/patent/US11441197B2

## CPC

- C12Q 1/6897: involving reporter genes operably linked to promoters
- C12N 15/1086: {Preparation or screening of expression libraries, e.g. reporter assays}
- C12Q 2525/143: incorporating a promoter sequence
- C12Q 2525/197: incorporating a spacer/coupling moiety
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

As demonstrated herein, when composite transcription factor binding sites do not function synergistically, mammalian promoters can be constructed according to simple design rules. Host-cell transcriptional machinery components were analyzed in silico to identify transcription factors with desired expression dynamics. Cognate binding sites were then comprehensively tested in homotypic and heterotypic architectures to assess modularity and determine the transcriptional activity exhibited by a single copy of each site. When elements were specifically selected to prevent combinatorial interactions, heterotypic promoter activities could be accurately modeled simply as a function of constituent binding site copy numbers. As binding site order, spacing, and orientation had minimal effect on promoter activity, blocks could be optimally combined and arranged in silico according to context-specific design-criteria. To demonstrate this, CHO cell promoters were created de-novo that exhibited designed activity levels and long-term expression stability in vitro.

## Claims

### Claim 1

A synthetic promoter comprising (a) a nucleotide sequence comprising 4 to 20 transcription factor regulatory elements (TFREs) and (b) a promoter core, wherein the nucleotide sequence comprising the TRFEs is located on upstream of the promoter core, wherein at least one third of the TFREs are individually selected from the group consisting of antioxidant RE (ARE), ETS binding site 1 (EBS1), endoplasmic reticulum stress RE (ERSE), and dioxin RE (DRE) TFREs, and wherein the promoter core comprises SEQ ID NO: 37.